Casey Chan graduated from Chung Shan Medical University, Taiwan in 2013 with Masters of Science in Biochemistry and Biotechnology. During her Master programs she studied the mechanisms of the anti-tumor drug Energi-702 in osteosarcoma cell with molecular biology techniques. Wanting to challenge herself, Casey made the switch to animal-based research and worked in Molecular and Genetic Imaging Core in Taipei Veterans General Hospital as a research assistant. She was handling two projects which are mainly related to stem cell treatment. One of the projects was umbilical cord mesenchymal stem cell (UCMSc) treatment on acute irradiation mice. The treatment improved the survival rate in mice, and complete blood count test were analysed from isolated bone marrow and blood. The second project was a combination therapy of MSCs and Radix Angelica in ischemic stroke rat. PET/CT and MRI imaging was used as a tool to diagnose ischemic lesions, and TTC and HE stain where used to observe brain pathology.When Casey first joined SINAPSE, Neurophotonics group on October 2015, she was working on neurovascular coupling and novel therapeutics for
When Casey first joined SINAPSE, Neurophotonics group on October 2015, she was working on neurovascular coupling and novel therapeutics for accute ischemia in rodent stroke models. Now she is currently working on understanding the leakage of organic aggregation-induced emission (AIE) dots in a stroke model rat and tumour nude mice.